Hemogenyx Pharmaceuticals (HEMO.L) Shares Dip 3.66%: Time To Risk?

The share price of Hemogenyx Pharmaceuticals has been steadily falling throughout the week. On September 9, the shares were worth 2.2363 GBP. The next day, the price fell to 2,0702 GBP. On August 14, the shares were released at 2.0025 GBP. During the last trading session, the shares fell by 3.66% and were trading at 1.9750 GBP. A member of the scientific advisory board of HemoGenyx Pharmaceuticals has received the American scientific equivalent of the Nobel Prize. The innovative work of H. Michael Shepard’s discovery of Herceptin, currently a widely prescribed breast cancer drug, was awarded the Lasker-DeBakey Clinical Medical Research Award in 2019. The Lasker Foundation said that Shepard’s research “has developed a new drug discovery plan that has already given tens of thousands of women time and quality of life.” Hemogenyx Executive Director Vladislav Sandler said:” We are very pleased that Dr Shepherd’s life-saving work has been recognized with this prestigious award, and we are lucky to have such an outstanding scientist advising advanced cancer research in our own organization.”

Lora Nilsson

Finance and Business reporterAfter graduating high school. Lora decided to travel and blog as a part-timer. Today she enjoys what she loves and works remotely as our finance and business reporter


Notice: ob_end_flush(): failed to send buffer of zlib output compression (0) in /home/zjrlrgmy/public_html/wp-includes/functions.php on line 5107